Petros Pharmaceuticals, Inc. (PTPI)
USD 0.06
(-7.76%)
USD 0.06
(-7.76%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1.61 Million USD | -11.28% |
| 2022 | 1.81 Million USD | 249.3% |
| 2021 | 519.64 Thousand USD | -31.67% |
| 2020 | 760.53 Thousand USD | -65.5% |
| 2019 | 2.2 Million USD | -66.03% |
| 2018 | 6.49 Million USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 1.43 Million USD | -7.95% |
| 2024 Q1 | 1.55 Million USD | -3.31% |
| 2023 Q1 | 2.03 Million USD | 12.27% |
| 2023 FY | 1.61 Million USD | -11.28% |
| 2023 Q3 | 2.5 Million USD | 14.73% |
| 2023 Q2 | 2.18 Million USD | 6.98% |
| 2023 Q4 | 1.61 Million USD | -35.61% |
| 2022 Q3 | 2.15 Million USD | 12.84% |
| 2022 Q2 | 1.9 Million USD | -1.75% |
| 2022 FY | 1.81 Million USD | 249.3% |
| 2022 Q1 | 1.94 Million USD | 273.88% |
| 2022 Q4 | 1.81 Million USD | -15.73% |
| 2021 Q1 | 560.86 Thousand USD | -26.25% |
| 2021 FY | 519.64 Thousand USD | -31.67% |
| 2021 Q4 | 519.64 Thousand USD | 0.23% |
| 2021 Q3 | 518.48 Thousand USD | 18.04% |
| 2021 Q2 | 439.23 Thousand USD | -21.69% |
| 2020 Q4 | 760.53 Thousand USD | -51.48% |
| 2020 FY | 760.53 Thousand USD | -65.5% |
| 2020 Q3 | 1.56 Million USD | -12.62% |
| 2020 Q2 | 1.79 Million USD | -8.02% |
| 2020 Q1 | 1.95 Million USD | -11.53% |
| 2019 Q4 | 2.2 Million USD | 0.0% |
| 2019 FY | 2.2 Million USD | -66.03% |
| 2019 Q1 | - USD | 0.0% |
| 2018 FY | 6.49 Million USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Cosmos Health Inc. | 4.78 Million USD | 66.374% |
| Safety Shot Inc | 1.86 Million USD | 13.867% |
| Bright Green Corporation | - USD | -Infinity% |
| Embecta Corp. | 152.1 Million USD | 98.941% |
| ANI Pharmaceuticals, Inc. | 111.19 Million USD | 98.552% |
| Aquestive Therapeutics, Inc. | 6.76 Million USD | 76.209% |
| Collegium Pharmaceutical, Inc. | 32.33 Million USD | 95.019% |
| Dynavax Technologies Corporation | 53.29 Million USD | 96.978% |
| Esperion Therapeutics, Inc. | 65.62 Million USD | 97.546% |
| Intra-Cellular Therapies, Inc. | 11.64 Million USD | 86.173% |
| Pacira BioSciences, Inc. | 104.35 Million USD | 98.457% |
| PainReform Ltd. | - USD | -Infinity% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | 71.919% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | 71.919% |
| SCYNEXIS, Inc. | - USD | -Infinity% |
| China SXT Pharmaceuticals, Inc. | 809.75 Thousand USD | -98.873% |
| Journey Medical Corporation | 10.2 Million USD | 84.221% |
| Alpha Teknova, Inc. | 11.59 Million USD | 86.11% |
| Procaps Group, S.A. | 96.83 Million USD | 98.337% |
| Theratechnologies Inc. | 6.06 Million USD | 73.452% |
| Harrow Health, Inc. | 10.86 Million USD | 85.181% |
| Sonoma Pharmaceuticals, Inc. | 2.71 Million USD | 40.773% |
| Biofrontera Inc. | 10.9 Million USD | 85.237% |
| DURECT Corporation | 2.21 Million USD | 27.427% |
| Supernus Pharmaceuticals, Inc. | 77.4 Million USD | 97.92% |
| Cronos Group Inc. | 30.33 Million USD | 94.692% |
| OptiNose, Inc. | 8.05 Million USD | 80.0% |
| Ironwood Pharmaceuticals, Inc. | 1.00 USD | -161039000.0% |
| Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
| RedHill Biopharma Ltd. | 5.69 Million USD | 71.743% |
| Organogenesis Holdings Inc. | 28.25 Million USD | 94.3% |
| Guardion Health Sciences, Inc. | 2.67 Million USD | 39.846% |
| Cumberland Pharmaceuticals Inc. | 4.6 Million USD | 65.063% |
| Radius Health, Inc. | 278.64 Million USD | 99.422% |
| Universe Pharmaceuticals INC | 3.34 Million USD | 51.832% |
| ProPhase Labs, Inc. | 3.84 Million USD | 58.074% |
| Phibro Animal Health Corporation | 265.91 Million USD | 99.394% |
| Procaps Group S.A. | 96.83 Million USD | 98.337% |
| Alvotech | 74.43 Million USD | 97.836% |
| TherapeuticsMD, Inc. | - USD | -Infinity% |
| Viatris Inc. | 3.46 Billion USD | 99.954% |
| Rockwell Medical, Inc. | 5.87 Million USD | 72.57% |
| Aytu BioPharma, Inc. | 12.63 Million USD | 87.253% |
| SIGA Technologies, Inc. | 64.21 Million USD | 97.492% |
| Tilray Brands, Inc. | 252.08 Million USD | 99.361% |
| Lifecore Biomedical, Inc. | 39.97 Million USD | 95.972% |
| Shineco, Inc. | 1.58 Million USD | -1.376% |
| PetIQ, Inc. | 159.3 Million USD | 98.989% |
| Regencell Bioscience Holdings Limited | -152.77 Thousand USD | 1154.073% |
| Incannex Healthcare Limited | -10.01 Million USD | 116.08% |
| Neurocrine Biosciences, Inc. | 38.3 Million USD | 95.795% |
| Alimera Sciences, Inc. | 1.87 Million USD | 14.295% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Assertio Holdings, Inc. | 37.68 Million USD | 95.727% |
| Shuttle Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Clever Leaves Holdings Inc. | 4.48 Million USD | 64.078% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -533.135% |
| Avadel Pharmaceuticals plc | 10.38 Million USD | 84.486% |
| Hempacco Co., Inc. | 2.54 Million USD | 36.664% |
| Talphera, Inc. | - USD | -Infinity% |
| Alvotech | 74.43 Million USD | 97.836% |
| Eagle Pharmaceuticals, Inc. | 47.79 Million USD | 96.631% |
| Lantheus Holdings, Inc. | 64.02 Million USD | 97.485% |
| Currenc Group, Inc. | 732.91 Thousand USD | -119.725% |
| Kamada Ltd. | 87.74 Million USD | 98.165% |
| Indivior PLC | 141.79 Million USD | 98.864% |
| Evoke Pharma, Inc. | 481.84 Thousand USD | -234.217% |
| Flora Growth Corp. | 8.5 Million USD | 81.072% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -533.135% |
| Evolus, Inc. | 10.99 Million USD | 85.357% |
| HUTCHMED (China) Limited | 50.25 Million USD | 96.796% |
| Amphastar Pharmaceuticals, Inc. | 105.83 Million USD | 98.478% |
| Akanda Corp. | 1.28 Million USD | -25.138% |